July 17, 2013 12:03 am | Updated October 18, 2016 02:05 pm IST - MUMBAI
Cipla has completed the acquisition of 100 per cent of the issued shares of Cipla Medpro South Africa for a consideration of 4,507 million South African rand (Rs.2,707 crore).
As a result, Cipla Medpro shares which were listed on the Johannesburg Stock Exchange (JSE) have been de-listed from Tuesday, Cipla said in a statement.
Cipla has a long-standing agreement with Cipla Medpro and provides a wide range of products to it across dosage forms.
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
